Leadxpro AG
Villigen, CH· latest recorded location
LEADXPRO AG is named on 2 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 5
- Inventors
- 4
- Granted in 2026 so far
- 1
- Most recent grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 7 documents
Recent patents
- Method of enabling pooled-library based nucleic acid constructs screening2 Jun 2026US 12,644,117 B2
- Functionalized aminotriazines19 Aug 2025US 12,391,670 B2
- Functionalized aminotriazines12 Mar 2026US 2026/0070892 A1
- Functionalized aminothiazoles27 Mar 2025US 2025/0101013 A1
- Pro-macrobodies for the enhancement of structure research9 Mar 2023US 2023/0072235 A1
- Method of enabling pooled-library based nucleic acid constructs screening29 Dec 2022US 2022/0411788 A1
- Functionalized aminotriazines23 Dec 2021US 2021/0395225 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.